Table 3.
Patients | Controls | |||
---|---|---|---|---|
W1 | W4 | W12 | ||
MD | 1.013 ± 0.046 | 0.991 ± 0.036 | 1.098 ± 0.076abc | 1.005 ± 0.016 |
FA | 0.958 ± 0.115 | 0.914 ± 0.148c | 0.915 ± 0.207 | 1.019 ± 0.049 |
NAA | 0.961 ± 0.069 | 0.850 ± 0.142ac | 0.678 ± 0.085abc | 1.012 ± 0.087 |
Cho | 0.935 ± 0.123 | 1.016 ± 0.295 | 0.951 ± 0.178 | 0.975 ± 0.064 |
Cr | 0.979 ± 0.067 | 0.960 ± 0.190 | 0.932 ± 0.149 | 0.988 ± 0.038 |
MD: mean diffusivity; FA: fractional anisotropy; NAA: N-acetylaspartate; Cho: choline; Cr: creatine; W1: the first week; W4: the fourth week; W12: the twelfth week.
Asymmetry indices: thalamic ipsilateral/contralateral MRI Parameter value in patients and right/left MRI Parameter value in controls.
aP< 0.05, Tukey test, compared to W1; bP< 0.05, Tukey test, compared to W4; cP< 0.05, Student's t test, compared to the control group.